Erschienen in:
01.10.2006
Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement By Abdalla et al. Editorial Review
verfasst von:
Reid B. Adams, MD, Daniel G. Haller, MD, Mark S. Roh, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 10/2006
Einloggen, um Zugang zu erhalten
Excerpt
Treatment of colorectal metastatic disease has changed dramatically over the past 10 years. Liver resection has been the only accepted curative treatment option for patients with metastatic colon cancer, but the introduction of better imaging, newer ablative techniques, improved systemic therapies and improved patient selection has increased the number of patients eligible for consideration for this goal. To date, there have been only modest prospective clinical trial efforts in this population to evaluate long-term benefits in relapse-free and overall survival, as well as, in patients who have undergone resection. This consensus conference is timely in bringing together leaders in the field in an effort to consolidate current approaches to this disease. This effort is laudable, focusing the discussion on the current standards for care of colorectal liver metastases (CLM), while highlighting the areas of controversy and the unanswered questions. Like all good academic endeavors, it raises as many questions as it answers. …
